AI

SOPHiA GENETICS raises USD 77 million to build US business

SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.

AI drug trials to scale up in 2019

Predictions are two a penny at this time of year, and no one will hold those who make the predictions to account. Tractica, a market intelligence agency, has put out a white paper with predictions on Artificial Intelligence in 2019. Amongst them is an expectation of advancement in AI-enabled drug trials.